Characteristic of milk whey culture with Propionibacterium freudenreichii ET-3 and its application to the inflammatory bowel disease therapy

Inflammopharmacology

Volumn 15, Issue 3, 2007, Pages 105-108

  Uchida, M ^a   Mogami, O ^a   Matsueda, K ^b  

^a MEIJI DAIRIES CORPORATION   (Japan)

^b National Saigata Medical Center   (Japan)

Author keywords

Constipation; DHNA; IBD, TNBS colitis; Prebiotic; Propionibacterium freudenreichii ET 3

Indexed keywords

1,4 DIHYDROXY 2 NAPHTHOIC ACID; DEXTRAN SULFATE; GROWTH PROMOTOR; MUCOSAL ADDRESSIN CELL ADHESION MOLECULE 1; PREBIOTIC AGENT; TRINITROBENZENESULFONIC ACID; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; BIFIDOBACTERIACEAE; BIFIDOBACTERIUM ADOLESCENTIS; CELL FREE SYSTEM; CELL POPULATION; COLITIS; DISEASE MODEL; DOSE RESPONSE; DRUG MECHANISM; DRUG SAFETY; HUMAN; INGESTION; LYMPHOCYTIC INFILTRATION; MILK; NONHUMAN; PILOT STUDY; PRIORITY JOURNAL; PROPIONIBACTERIUM FREUDENREICHII SHERMANII; REVIEW; TABLET; TREATMENT DURATION; ULCERATIVE COLITIS; WHEY;

ANIMALS; BIFIDOBACTERIUM; CULTURE MEDIA; FERMENTATION; HUMANS; INFLAMMATORY BOWEL DISEASES; MICE; MILK; PROBIOTICS; PROPIONIBACTERIUM; RATS;

EID: 34347390638     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-007-1557-5     Document Type: Review

References (21)

1. Cherbut, C., Michel, C., Lecannu, G. (2003). The prebiotic characteristics of fructooligosaccharides are necessary for reduction of TNBS-induced colitis in rats. J. Nutr. 133, 21-27.
2. Fuller, R. (1989). Prebiotics in man and animals. J Apply Bacteriol. 66, 365-378.
3. Gibson, G. R., Roberfroid, M. B. (1995). Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 222, 1401-1412.
4. Hanai, H., Kanauchi, O., Mitsuyama, K. et al. (2004). Germinated barley foodstuff prolongs remission in patients with ulcerative colitis. Int. J. Mol.Med. 13, 643-647.
5. Hans, W., Scholmerich, J., Gross, V. et al. (2000). The role of the resident intestinal flora in acute and chronic dextran sulfate sodium-induced colitis in mice. Eur. J. Gastroenterol. Hepatol. 12, 267-273.
6. Hojo, K., Yoda, N., Tsuchita, H. et al. (2002). Effect of ingested culture of Propionibacterium freudenreichii ET-3 on fecal microflora and stool frequency in healty females. Biosci. Microflora 21, 115-120.
7. Isawa, K., Hojo, K., Yoda, N. et al. (2002). Isolation and identification of a new bifidogenic growth stimulator produced by Propionibacterium freudenreichii ET-3. Biosci. Biotechnol. Biochem. 66, 679-681.
8. Kaneko, T., Mori, H., Iwata, M. et al. (1994). Growth stimulator for bifidobacteria produced by Propionibacterium freudenreichii and several intestinal bacteria. J. Dairy Sci. 77, 393-404.
9. Kanauchi, O., Iwanaga, T., Andoh, A. et al. (2001a). Dietary fiber fraction of germinated barley foodstuff attenuated mucosal damage and diarrhea, and accelerated the repair of the colonic mucosa in an experimental colitis. J. Gastroenterol. Hepatol. 16, 160-168.
10. Kanauchi, O., Iwanaga, T., Mitsuyama, K. (2001b). Germinated barley foodstuff feeding. A novel neutraceutical therapeutic strategy for ulcerative colitis. Digestion 63 Suppl 1, 60-67.
11. Kanauchi, O., Mitsuyama, K., Homma, T. et al. (2003). Treatment of ulcerative colitis patients by long-term administration of germinated barley foodstuff: multi-center open trial. Int. J. Mol. Med. 12, 701-704.
12. Kaneko, T., Noda, K. (1996). Bifidogemic growth stimlator produced by propionic acid bacteria. Jpn. J. Dairy Food Sci. 45, 83-91 (in Japanese).
13. Kaneko, T. (1999). A novel bifidogenic growth stimulatore produced by Propionibacterium freudenreichii. Boiscience Microflora 18, 73-80.
14. Mori, H., Sato, Y., Taketomo, N. et al. (1997). Isolation and structural identification of bifidogenic growth stimulator produced by Propionibacterium freudenreichii. J. Dairy Sci. 80, 1959-1964.
15. Okada, Y., Tsuzuki, Y., Miyazaki, J. et al. (2006). Propionibacterium freudenreichii component 1.4-dihydroxy-2-naphthoic acid (DHNA) attenuates dextran sodium sulphate induced colitis by modulation of bacterial flora and lymphocyte homing. Gut 55, 681-688.
16. Osman, N., Adawi, D., Ahrne, S. et al. (2004). Modulation of the effect of dextran sulfate sodium-induced acute colitis by the administration of different probiotic strains of Lactobacillus and Bifidobacterium. Dig. Dis. Sci. 49, 320-327.
17. Parker, R. B. (1974). Probiotics, the other half of the antibiotic story. Animal Nutr. Health 29, 4-8.
18. Suzuki, A., Mitsuyama, K., Koga, H. et al. (2006). Bifidogenic growth stimulator for the treatment of active ulcerative colitis: a pilot study. Nutrition 22, 76-81.
19. Tursi, A., Brandimarte, G., Giorgetti, G. M. et al. (2004). A. Low-dose balsalazide plus a high-potency probiotic preparation is more effective than balsalazide alone or mesalazine in the treatment of acute mild-to-moderate ulcerative colitis. Med. Sci. Monit. 10, PI126-PI131.
20. Uchida, M., Mogami, O. (2005a). An improved and reliable method for the induction of colitis in rats using 2,4,6-trinitrobenzene sulfonic acid. J. Pharmacol. Sci. 97, 285-288.
21. Uchida, M., Mogami, O. (2005b). Milk whey culture with Propionibacterium freudenreichii ET-3 is effective on the colitis induced by 2,4,6-trinitrobenzene sulfonic acid in rats. J. Pharmacol. Sci. 99, 329-334.